Reviewing the capabilities, limitations, and sensitivities of various package integrity testing methodologies available at the time.
PDA Technical Report 27 was developed by a task force of industry experts to harmonize the concept of pharmaceutical package integrity. It bridges the gap between historical quality control mindsets and modern, science-based engineering standards. TR 27 shifts the industry focus away from probabilistic, destructive testing (such as the traditional blue dye ingress test) toward deterministic, non-destructive methodologies that offer higher sensitivity and data integrity. Core Principles of Container Closure Integrity (CCI)
, titled "Pharmaceutical Package Integrity," was originally published in 1998 by the Parenteral Drug Association (PDA) . It provides comprehensive guidance on evaluating the barrier qualities of pharmaceutical packaging, specifically focusing on sterile products. Report Overview
*Disclaimer: This summary
| Aspect | PDA TR 27 (2014 Rev) | PDA TR 86 (2021) | |--------|----------------------|------------------| | Focus | Fundamental methodology | Emerging challenges & case studies | | Leak size guidance | ≥0.2 µm equivalent | Covers down to sub-micron | | Technologies | Traditional methods | Includes laser-based, microcurrent, and headspace analysis | | Regulatory alignment | Precedes USP <1207> shift | Fully aligned with USP <1207> (2016-on) | | Practical examples | Limited | Extensive industrial case studies |
"TR 27 says we don't just fix the one vial," Elias explained, pointing to the section on Maintenance of Sterility . "We find the root cause in the capping pressure."
While the remains a foundational text for understanding the physics of package leaks, regulatory expectations have evolved significantly since its initial release. The USP Alignment pda technical report 27 pdf
Integrating integrity testing into the entire product lifecycle, from initial component selection and package development to routine production line monitoring. Key Concepts and Methodologies Covered
: Submerging containers in a liquid dye solution under a vacuum or pressure cycle, then visually inspecting or using UV-Vis spectroscopy to check for dye inside the container. Deterministic Test Methods
: Selecting dimensionally compatible primary packaging components (e.g., matching a glass vial with the correct elastomeric stopper and aluminum crimp cap). TR 27 shifts the industry focus away from
The report addresses one of the most fundamental questions in sterile drug manufacturing: How can a manufacturer be certain that the container-closure system effectively prevents microbial ingress and maintains product quality? Unlike routine sterility testing (which is destructive and statistically limited), package integrity testing provides a holistic, non-destructive (or minimally destructive) approach to assuring container closure integrity (CCI).
: While it emphasizes packaging for sterile products , the principles are applicable to any nonporous barrier system protecting a pharmaceutical product.